Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03553836 |
|---|---|
| Brief Title: | Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716) |
| First Submitted : | June 1, 2018 |
| First Submitted that Met QC Criteria : | June 1, 2018 |
| First Posted : | June 12, 2018 |
| Results First Submitted : | May 26, 2022 |
| Results First Submitted that Met QC Criteria : | May 26, 2022 |
| Results First Posted : | June 24, 2022 |
| Last Update Submitted that Met QC Criteria : | February 8, 2024 |
| Last Update Posted : | February 9, 2024 |